Keywords: Multiple Sclerosis, Multiple Sclerosis
Motivation: Artificial intelligence (AI) is a promising tool that must be used to its full potential. Acquiring knowledge related to its uses and limitations is essential.
Goal(s): Establish the utility of new anatomic biomarkers using an AI tool for brain and lesion volumetry in patients with multiple sclerosis.
Approach: Analyze the correlation between lesion burden and specific structural brain atrophy using AI segmentation and volumetry in patients with multiple sclerosis.
Results: Significant statistical correlation was found between lesion burden and thalamic atrophy in patients with MS, opening the possibility of using thalamic volumetry as a biomarker for disease progression.
Impact: Total lesion burden in MS patients correlates with structural brain volume loss mediated by destruction of white matter tracts and Wallerian degeneration. Establishing volumetric biomarkers using artificial intelligence may provide useful information regarding disease progression and long-term prognosis.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords